As for the mechanism by which entrectinib inhibits the growth of ependymoma-derived CTCs and the PDX model (Figure 4C,D and Figure 6B), judging from the suppressed expression of phosphate AKT in PDX specimens after treatment (Figure 6C), it is likely to be achieved via non-NTRK pathways. This evidence concerns the gene AKT1 and ependymoma.